DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Tuberculosis Diagnostics and Treatment Market Analysis & Trends- Therapeutics, Diagnosis - Forecast to 2025" report to their offering.
The Global Tuberculosis Diagnostics and Treatments Market is poised to grow at a CAGR of around 4.2% from 2015 to 2025. Some of the prominent trends in the market include the technologies that may replace smear microscopy, major investments in basic research related to Mycobaterium tuberculosis diagnosis, demand for Xpert MTB/RI in the tuberculosis diagnostics landscape and the potential markets in emerging countries around the world.
This industry report analyzes the global markets for Tuberculosis Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
- Abbott Laboratories,
- Akonni Biosystems, Inc.
- Alere, Inc
- Becton Dickinson
- Cepheid Inc
- EIKEN Chemical
- Epistem Holdings Plc
- F. Hoffmann-La Roche AG
- Gen-Probe Inc.
- Hain LifeSciences
- Hologic Corporation
- Thermo Fisher Scientific, Inc
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Tuberculosis Diagnostics and Treatments Market, By Therapeutics
5 Tuberculosis Diagnostics and Treatments Market, By Diagnosis
6 Tuberculosis Diagnostics and Treatments Market, By Geography
7 Key Player Activities
8 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/2hwq8b/global